About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Private PAIR 7.0 Product Launch | Main | Another Big Genentech Licensing Deal »

December 12, 2006

Gene Therapy Vector Licensed by Amsterdam Molecular Therapeutics

    By Jason Derry --

Targeted Genetics Targeted Genetics Corp. has announced a non-exclusive licensing deal with Amsterdam Molecular Therapeutics B.V. relating to the use of the AAV1 (Adeno-Associated Virus Type 1) vector.  The licensed AAV1 vector is covered by U.S. Patent Nos. 6,759,237 and 7,105,345.  AMT intends to use the vector for developing therapeutics for treating type I and type V lipoprotein lipase (LPL) deficiency.  In particular, AMT will use the vector in the development of its lead gene product, AMT-011, which is in Phase II clinical trials.  AMT and Targeted Genetics are both focused on developing gene therapies for a variety of diseases.

Amsterdam Molecular Therapeutics Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 02:43 PM in Biotech/Pharma Business, Licensing |

Comments

The comments to this entry are closed.

March 2021

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      

Categories

Archives

More...